PUBLISHER: QYResearch | PRODUCT CODE: 1091510
PUBLISHER: QYResearch | PRODUCT CODE: 1091510
Due to the COVID-19 pandemic, the global EVA Infusion Bags market size was value at US$ 140.13 million in 2021 and is forecast to be a readjusted size of US$ 218.54 million by 2028 with a CAGR of 6.54% during the forecast period 2022-2028.
The global main manufacturers of EVA Infusion Bags include B. Braun, Baxter International, ICU Medical, Metrix, Kapsam Health Products, Bexen Medical, Valmed, and Technoflex, etc. In 2021, the global six largest players have a share approximately 73.22% in terms of revenue.
The North America EVA Infusion Bags market size was US$ 48.15 million in 2021, while China was about US$ 11.46 million. The proportion of the China was 8.18% in 2021 and it is predicted that the share will reach 8.96% in 2028, trailing a CAGR of 7.82% through the analysis period. As for the Europe EVA Infusion Bags landscape, Germany is projected to reach US$ 19.18 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 7.4 % and 7.13% respectively for the next 6-year period.
Fully considering the economic change by the COVID-19, Single Chamber accounting for 62.62% of the EVA Infusion Bags global market in 2021, is projected to value US$ 131.41 million by 2028, growing at a revised 5.98% CAGR from 2022 to 2028. While Hospital segment is altered to an 6.32% CAGR throughout this forecast period and will hold a share about 69.02% in 2028.
The global EVA Infusion Bags market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global EVA Infusion Bags market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.